Sessions

A one year follow up about two cases of optic neuritis under golimumab therapy (anti-TNFa) for ankylosing spondylitis revealing demyelinating disorders and multiple sclerosis

[Speaker] Christophe Maucorps:1
[Co-author] Pierre Branger:2, Nathalie Derache:2, Vassili Chawadronow:1, Antoine Coquerel:1, Gilles Defer:2, Sophie Fedrizzi:1
1:Pharmacology, CHU Caen, France, 2:Neurology, CHU Caen, France

Pharmacovigilance in the paediatric respiratory medicine. The misuse of some mucolytic drugs in children

[Speaker] Ioan Magyar:1
[Co-author] Madalina Vidican:1, Cristian Sava:2, Andrea Badale:3
1:Pharmacology, University of Oradea, Romania, 2:Paediatrics, University of Oradea, Romania, 3:Pharmacology Institute, University of Debrecen, Hungary

Adverse Drug Reactions Reporting in a Teaching Hospital in Taiwan

[Speaker] Yuhong Lin:1
[Co-author] Hsinhui Huang:1
1:Pharmacy, Kaohsiung Veterans General Hospital Tainan Branch, Taiwan

Development of trigger tools for detection of adverse drug events in Chinese geriatric inpatients using Delphi method

[Speaker] Qiaozhi Hu:1
[Co-author] Mei Zhan:1, Bin Wu:1, Zhaoyan Chen:2, Ting Xu:1
1:Department of Clinical Pharmacy, West China Hospital of Sichuan University, China, 2:West China Medical School of sichuan university, China

Trend of Antimicrobial use and drug resistant bacteria and the comparison between our facility and 4 other facilities in Fukui Prefecture

[Speaker] Hiroko Shigemi:1,2
[Co-author] Katsunori Tai:2, Maiko Kadowaki:1, Akikazu Shimada:1, Miwa Morikawa:1, Yukihiro Umeda:1, Yuko Waseda:1, Masaki Anzai:1, Tamotsu Ishizuka:1, Hiromichi Iwasaki:2
1:Department of Respiratory Medicine, University of Fukui Hospital, Japan, 2:Department of Infection Control and Prevention, University of Fukui Hospital, Japan

MEDICATION DISCREPANCIES AND POTENTIALLY INAPPROPRIATE MEDICATIONS IN INTERNAL MEDICINE UNITS: AN ITALIAN EXPERIENCE

[Speaker] Francesco Scaglione:1
[Co-author] Giovanni Ceccarelli:2, Pietro Nunnari:1, Angelo V Romano:1, Fabrizio Colombo:3
1:Department of Oncology and hemato-oncology, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan, Italy, 2:Quality and Clinical Risk Department, Niguarda Hospital, Milan, Italy, 3:Internal Medicine Department, Niguarda Hospital, Milan, Italy

Are Dietary/Nutritional Supplement products disguised therapeutics in South Africa? - Uncovering the steroid profile delivery system

[Speaker] Gary Gabriels:1,4
[Co-author] Mike Lambert:2, Pete Smith:3, Lubbe Wiesner:3, Yoga Coopoo:4
1:Pharmacy and Pharamacology, University of Witwatersrand, South Africa, 2:Division of Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, Faculty of Health Sciences, South Africa, 3:Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Faculty of Health Sciences, South Africa, 4:Department of Sport and Movement Studies, University of Johannesburg, Faculty of Health Science, Gauteng, South Africa

Pharmacovigilance Study of Antipsychotics in New Zealand using Three Outcomes Databases

[Speaker] David M Reith:1,2
[Co-author] Andy Tomlin:2, John Fountain:2, Alesha Smith:2,3, Murray Tilyard:1,2
1:Dunedin School of Medicine, University of Otago, New Zealand, 2:Best Practice Advocacy Centre, New Zealand, 3:School of Pharmacy, University of Otago, New Zealand

Ambrisentan induced Hypersensitivity reaction: A Rare case report

[Speaker] Sereen R Thomson:1
[Co-author] Bharti Chogtu Magazine:2
1:Postgraduate student, Department of Pharmacology, Kasturba Medical College, Manipal, Karnataka, India, 2:Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal, Karnataka, India

Adverse event reporting by consumers in the United States

[Speaker] Tadashi Toki:1
[Co-author] Shunsuke Ono:1
1:Laboratory of Regulation and Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan

Consideration of post-marketing drug safety assessment in hospitals

[Speaker] Takahiro Kawakami:1,2
[Co-author] Katsuhiko Nagase:1, Yuko Yokoi:1,2, Akiko Kuwajima:1, Shingo Itai:2, Yusuke Hara:2, Tsutomu Shimada:2, Yoshimichi Sai:2, Toshinori Murayama:1,3
1:Innovative Clinical Research Center, Kanazawa University, Japan, 2:Department of Hospital Pharmacy, University Hospital, Kanazawa University, Japan, 3:Department of Clinical Development, Kanazawa University Hospital, Japan

The development of Chinese elderly people PIM list

[Speaker] Sai Wang:1
[Co-author] Yan Yan:2, Xiaolan Zhang:3, Lan Zhang:1, Yuqin Wang:1
1:Xuan Wu Hospital, Capital Medical University, China, 2:Beijing Pharmaceutical centralized purchasing service center, China, 3:Beijing Jing Lu He Hospital, Capital Medical University, China

Assessment of Dabigatran, Rivaroxaban and Apixaban With Respect to Drug-Drug Interaction in a University Hospital

[Speaker] Sena Turkes:1
[Co-author] Osman Karakus:1, Dilek Yumus Basak:2, Sureyya Barun:1, Canan Uluoglu:1
1:Department of Pharmacology, Gazi University Faculty of Medicine, Turkey, 2:Gazi Hospital, Gazi University Faculty of Medicine, Turkey

CLINICAL PHENOTYPE AND OUTCOME OF DRESS CASES IN THE SPANISH AND LATIN-AMERICAN DILI REGISTRIES

[Speaker] MI Lucena:1
[Co-author] I Medina-Caliz:1, M Almarza:1, C Stephens:1, M Robles-Diaz:1, Mc Fernandez:2, P Gines:3, F Bessone:4, N Hernandez:5, Rj Andrade:1
1:UGC Aparato Digestivo y Servicio de Farmacologia Clinica. Instituto de Investigacion Biomedica de Malaga (IBIMA). Hospital Universitario Virgen de la Victoria. Universidad de Malaga, CIBERehd, Malaga, Spain, 2:Complejo Hospitalario Torrecardenas, Almeria, Spain, 3:Liver Unit, Hospital Clinic, CIBERehd, Barcelona, Spain, 4:Hospital Provincial del Centenario, Rosario, Argentina, 5:Hospital de Clinicas, Montevideo, Uruguay

The Global Risk Analysis as a tool to secure drug management of clinical trials in hospitals

[Speaker] Jacques A Weissenburger:1,3
[Co-author] Juliette Godard:1, Caroline Ly:1, Anne Daguenel:2, Christine Fernandez:2,3,4, Tabassome Simon:1,3
1:Department of Clinical Pharmacology & Clinical research Platform (CRB, CRC, URC), Assistance-Publique Hopitaux de Paris, Paris, France, 2:Depatment of Pharmacy, Assistance-Publique Hopitaux de Paris, PARIS, France, 3:Sorbonne Universites, UPMC Paris Univ-06, PARIS, France, 4:INSERM, Institut Pierre Louis, Epidemiologie et Sante Publique, France

A case of Hyper sexuality probably associated with Clozapine

[Speaker] Sereen R Thomson:1
[Co-author] Navin Patil:2
1:Pharmacology, Postgraduate student, Department of Pharmacology, Kasturba Medical College, Manipal, Karnataka, India, 2:Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal, Karnataka, India

Evaluation of antibiotic prescribing in Kabul

[Speaker] Rohullah Roien:1
[Co-author] Arif Athaie:1, Zabihullah Iqbal:1, Abbas Ali Ramoozi:1
1:Pharmacology, Afghanistan

TNFalpha inhibitors and amyotrophic lateral sclerosis: a risk factor ?

[Speaker] Antoine Coquerel:1
[Co-author] Nadine Petitpain:2, David Devos:3, Haleh Bagheri:4, Fanny Rocher:5, Kamel Masmoudi:6
1:Regional Pharmacovigilance Center of Caen, UMR University of Caen Normandie, Inserm U1075, France, 2:Clinical Pharmacology, Toxicology, University Hospital of Nancy, Regional Pharmacovigilance Center, France, 3:Department of Medical Pharmacology and Department of Neurology, ALS center Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France, 4:Department of clinical and medical pharmacology, Midi-Pyrenees Pharmacovigilance and pharmacoepidemiology center, INSERM, UMR 1027, University hospital of Toulouse, France, 5:Regional Pharmacovigilance center of Nice, University hospital of Nice, France, 6:Regional Pharmacovigilance center of Amiens, University hospital of Amiens, France

Assessment of drug prescribing pattern using WHO indicators in outpatient departments of a tertiary care teaching hospital in North India

[Speaker] Sanjay Khattri:1
[Co-author] Sartaj Hussain:1, Suraj S Yadav:1, Manish Bajpai:2, Kamal K Sawlani:3
1:Department of Pharmacology, King George's Medical University, U. P., Lucknow, India, 2:Department of Physiology, King George's Medical University, U. P., Lucknow, India, 3:Department of Medicine, King George's Medical University, U. P., Lucknow, India

Antithrombotic drug-drug interaction alerts in MedChart™

[Speaker] Paul K. L. Chin:1,2
[Co-author] Amanda M. Crawford:2, Qianyi Chuah:1, Matt P. Doogue:1,2
1:Canterbury District Health Board, New Zealand, 2:University of Otago, Christchurch, New Zealand

Adapting and applying common methods used in pharmacovigilance to the environment: a possible starting point for the implementation of eco-pharmacovigilance

[Speaker] Bingshu He:1
[Co-author] Jun Wang:2
1:Hubei Woman and Child Hospital, China, 2:Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, China

Reduced risk of aortic aneurysms associated with fluoroquinolone therapy

[Speaker] Jorge E Machado-Alba:1
[Co-author] Juan Pablo Castano-Montoya:1, Andres Gaviria-Mendoza:1, Julio Cesar Arce-Fajardo:1, Manuel Enrique Machado-Duque:1, William Martinez:2, Julio Cesar Sanchez-Naranjo:2
1:Grupo de Investigacion en Farmacoepidemiologia y Farmacovigilancia, Universidad Tecnologica de Pereira. Asociacion Colombiana de Farmacologia, Colombia, 2:Facultad de Ciencias de la Salud. Universidad Tecnologica de Pereira. Pereira, Colombia

Drugs with anticholinergic potential and risk of falls with hip fracture in the elderly: A case-control study

[Speaker] Jorge E Machado-Alba:1
[Co-author] Manuel E Machado-Duque:1, Juan P Castano-Montoya:1, Diego A Medina-Morales:1, Alejandro Castro-Rodriguez:1, Alexandra Gonzalez-Montoya:1
1:Grupo de Investigacion en Farmacoepidemiologia y Farmacovigilancia, Universidad Tecnologica de Pereira. Asociacion Colombiana de Farmacologia. , Colombia

DO DIFFERENT BRANDS OF IBUPROFEN POSSESS DIFFERENT ANTI-INFLAMMATORY POTENCIES?

[Speaker] Udeme O Georgewill:1
[Co-author] Veraline C Obeta:1, Owunari A Georgewill:1
1:PHARMACOLOGY, University Of Port Harcourt, Nigeria

Treatment patterns of antipsychotics and clinical features in patients with schizophrenia at the Psychiatric Ward of Tertiary hospital in Jakarta, Indonesia

[Speaker] Wawaimuli Arozal:1
[Co-author] Diana Wijaya:1, Vivian Soetikno:1, Nurmiati Amir:2
1:Department of Pharmacology Faculty of Medicine Universitas Indonesia, Indonesia, 2:Department of Psychiatry, Faculty of Medicine Universitas Indonesia, Indonesia

The perceived impact of medicines, foods and substances taken by mother on their breastfed baby

[Speaker] Hilai Ahmadzai:1
[Co-author] Lisa Bg Tee:1, Richard Parsons:1, Andrew P Crowe:1
1:School of Pharmacy and Biomedical Science, Curtin University, Australia

Prevalence and characteristics of medicine use among pregnant women in a Kenyan hospital

[Speaker] Margaret N. Oluka:1
[Co-author] George M. Kirira:1, Erick M. Guantai:1, Brian Godman:2,3, Charles K. Maitai:1
1:Pharmacology and Pharmacognosy, University of Nairobi, Kenya, 2:Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, Scotland, UK, 3:Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

The risk of drug-drug interactions with paracetamol in a population of hospitalized geriatric patients

[Speaker] Kim P Dalhoff:1
[Co-author] Lykke I Olsen:1, Luana S Castillo:2, Charlotte Vermehren:1
1:Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Denmark, 2:Geriatric Medicine, Bispebjerg and Frederiksberg University Hospital, Denmark

Pharmaco-economic and clinical impact of pre-analytical non conformities in cyclosporin therapeutic drug monitoring

[Speaker] Mehdi Bouhlel:1
[Co-author] Emna Gaies:1, Rim Charfi:1, Issam Salouage:1, Nadia Jebabli:1, Mouna Ben Sassi:1, Hanene El Jebari:1, Anis Klouz:1, Raidh Daghfous:1, Sameh Trabelsi:1
1:Clinical Pharmacology Department, National Centre of Pharmacovigilance, Tunisia

Tramadol use in Denmark, Norway, and Sweden: a population-based study

[Speaker] Astrid Blicher Schelde:1
[Co-author] Espen Jimenez-Solem:1,2, Anne Mette Skov Soerensen:1, Morten Hindsoe:1, Robert Eriksson:1,3
1:Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Denmark, 2:Department of Clinical Medicine, University of Copenhagen, Denmark, 3:Department of Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark

Clinical pharmacology consultation and outcomes associated with pregnancy exposure to pregnancy-contraindicated therapy

[Speaker] Viktorija Erdeljic Turk:1
[Co-author] Iveta Mercep:1,2, Ksenija Makar- Ausperger:1, Matea Radacic Aumiler:1, Robert Likic:1,2, Ivana Cegec:1, Iva Kraljickovic:1
1:Department of Medicine, Division of Clinical Pharmacology, University Hospital Zagreb, Croatia, 2:University of Zagreb Medical School, Croatia

How to proceed during Induced voriconazole-associated hallucination by Imipenem

[Speaker] Mahmoud Zarati:1
[Co-author] Ons Ben Dhia:1
1:Intern at National Center for Bone Marrow Transplantation, Tunisia

Identification of available tools for the assessment of causality and severity in paediatric population

[Speaker] Donato Bonifazi:1
[Co-author] Kejla Musaraj:1, Adelaida Tushe:1, Cristina Manfredi:1, Mariagrazia Felisi:1
1:Consorzio per Valutazioni Biologiche e Farmacologiche, Italy

Advanced Search